4,000
Participants
Start Date
November 27, 2023
Primary Completion Date
March 31, 2025
Study Completion Date
November 30, 2025
AdCLD-CoV19-1 OMI
3000 participants will receive investigational product (AdCLD-CoV19-1 OMI) via intramuscular administration in the deltoid muscle
Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
1000 participants will receive investigational product (Comirnaty Bivalent) via intramuscular administration in the deltoid muscle
The Medical City-Iloilo, Iloilo City
West Visayas State University Medical Center, Iloilo City
Tropical Disease Foundation, Inc., Makati
Far Eastern University - Nicanor Reyes Medical Foundation, Quezon City
Dong-a University Hospital, Busan
Kyungpook National University Hospital, Daegu
Chungnam National University Hospital, Daejeon
Chonnam National University Hospital, Gwangju
Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do
Korea University Ansan Hospital, Gyeonggi-do
The Catholic University of Korea, ST. Vincent's Hospital, Gyeonggi-do
Gachon University Gil Medical Center, Incheon
Inha University Hospital, Incheon
Hallym University Kangnam Sacred Heart Hospital, Seoul
Korea University Guro Hospital, Seoul
The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul
Veterans Health Service Medical Center, Seoul
Cellid Co., Ltd.
INDUSTRY